{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:13:10Z","timestamp":1790413990881,"version":"4.1.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.amjmed.2007.08.011","type":"journal-article","created":{"date-parts":[[2007,10,3]],"date-time":"2007-10-03T07:12:27Z","timestamp":1191395547000},"page":"S26-S34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"S2","title":["Prevention and Management of Venous Thromboembolism in Pregnancy"],"prefix":"10.1016","volume":"120","author":[{"given":"Andra H.","family":"James","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2007.08.011_bib1","first-page":"166","article-title":"Venous thrombosis: on the history of Virchow\u2019s Triad","volume":"81","author":"Dickson","year":"2004","journal-title":"University of Toronto Medical Journal"},{"key":"10.1016\/j.amjmed.2007.08.011_bib2","series-title":"Normal and Problem Pregnancies","first-page":"63","article-title":"Maternal physiology in pregnancy","author":"Gordon","year":"2002"},{"key":"10.1016\/j.amjmed.2007.08.011_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1471-0528.1997.tb11043.x","article-title":"An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy","volume":"104","author":"Macklon","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib4","series-title":"Normal and Problem Pregnancies","first-page":"1033","article-title":"Respiratory diseases in pregnancy","author":"Whitty","year":"2002"},{"key":"10.1016\/j.amjmed.2007.08.011_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1067\/mob.2001.107919","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study","volume":"184","author":"Danilenko-Dixon","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib6","first-page":"264","article-title":"Prolonged bedrest during pregnancy: does the risk of deep vein thrombosis warrant the use of routine heparin prophylaxis?","volume":"6","author":"Carr","year":"1997","journal-title":"J Matern Fetal Med"},{"key":"10.1016\/j.amjmed.2007.08.011_bib7","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1067\/mob.2000.105405","article-title":"The prevalence of thromboembolic events among women with extended bed rest prescribed as part of the treatment for premature labor or preterm premature rupture of membranes","volume":"182","author":"Kovacevich","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000076711","article-title":"Leiden mutation, bed rest and infection: simultaneous triggers for maternal deep-vein thrombosis and neonatal intracranial hemorrhage?","volume":"19","author":"Sikovanyecz","year":"2004","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.amjmed.2007.08.011_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1521-6926(03)00021-5","article-title":"Haemostatic changes in pregnancy","volume":"16","author":"Bremme","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib10","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1111\/j.1742-4658.2005.04879.x","article-title":"The undecided serpin: the ins and outs of plasminogen activator inhibitor type 2","volume":"272","author":"Medcalf","year":"2005","journal-title":"FEBS J"},{"key":"10.1016\/j.amjmed.2007.08.011_bib11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ajog.2004.11.037","article-title":"Thrombosis during pregnancy and the postpartum period","volume":"193","author":"James","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00006254-199904000-00023","article-title":"Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation","volume":"54","author":"Ray","year":"1999","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.amjmed.2007.08.011_bib13","unstructured":"Postpartum Hemorrhage: Postpartum Hemorrhage Initiative, Office of Health, Infectious Diseases and Nutrition, Bureau for Global Health, US Agency for International Development. http:\/\/www.pphprevention.org\/pph.php. Accessed September 3, 2007."},{"key":"10.1016\/j.amjmed.2007.08.011_bib14","first-page":"1","article-title":"Pregnancy-related mortality surveillance\u2014United States, 1991\u20131999","volume":"52","author":"Chang","year":"2003","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.amjmed.2007.08.011_bib15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2007.08.011_bib16","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2005.11.008","article-title":"Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality","volume":"194","author":"James","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1471-0528.1990.tb01812.x","article-title":"Late symptoms after pregnancy-related deep vein thrombosis","volume":"97","author":"Bergqvist","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.thromres.2003.09.013","article-title":"Long-term outcome of deep venous thrombosis during pregnancy treated with unfractionated heparin or low molecular weight heparin","volume":"111","author":"Ulander","year":"2003","journal-title":"Thrombosis Research"},{"key":"10.1016\/j.amjmed.2007.08.011_bib19","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1053\/ejvs.2001.1499","article-title":"A 16-year haemodynamic follow-up of women with pregnancy-related medically treated iliofemoral deep venous thrombosis","volume":"22","author":"Rosfors","year":"2001","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.amjmed.2007.08.011_bib20","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0002-9378(98)70155-3","article-title":"Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations","volume":"179","author":"Grandone","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib21","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM200002103420602","article-title":"Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium","volume":"342","author":"Gerhardt","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2007.08.011_bib22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1471-0528.2000.tb13281.x","article-title":"Prothrombin 20210 G-- >A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy","volume":"107","author":"McColl","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.amjmed.2007.08.011_bib23","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1067\/mob.2000.106820","article-title":"Genetic factors associated with thrombosis in pregnancy in a United States population","volume":"183","author":"Dilley","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib24","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1055\/s-0037-1613085","article-title":"Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium","volume":"87","author":"Martinelli","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjmed.2007.08.011_bib25","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood.V85.6.1504.bloodjournal8561504","article-title":"High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)","volume":"85","author":"Rosendaal","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2007.08.011_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"Thrombophilia in pregnancy: a systematic review","volume":"132","author":"Robertson","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib27","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/01.ATV.16.6.742","article-title":"Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency: a cooperative, retrospective study","volume":"16","author":"Pabinger","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-0038-1645218","article-title":"Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women","volume":"63","author":"Conard","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjmed.2007.08.011_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000299460","article-title":"Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombin","volume":"14","author":"Hellgren","year":"1982","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.amjmed.2007.08.011_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00001703-199804000-00010","article-title":"Inherited thrombophilia and pregnancy","volume":"10","author":"Girling","year":"1998","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib31","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.1997.00440390101013","article-title":"A retrospective review of 61 patients with antiphospholipid syndrome: analysis of factors influencing recurrent thrombosis","volume":"157","author":"Krnic-Barrie","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2007.08.011_bib32","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/1529-0131(200106)44:6<1466::AID-ART242>3.0.CO;2-C","article-title":"High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin","volume":"44","author":"Erkan","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2007.08.011_bib33","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1001\/archinte.1989.00390100059015","article-title":"Heparin therapy during pregnancy: risks to the fetus and mother","volume":"149","author":"Ginsberg","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2007.08.011_bib34","first-page":"1134","article-title":"Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies","volume":"108","author":"Lepercq","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/j.amjmed.2007.08.011_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJMe020061","article-title":"Clotting and hemorrhage in the placenta\u2014a delicate balance","volume":"347","author":"Roberts","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2007.08.011_bib36","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1056\/NEJM200011163432002","article-title":"Safety of withholding heparin in pregnant women with a history of venous thromboembolism","volume":"343","author":"Brill-Edwards","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2007.08.011_bib37","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low-molecular-weight heparin in pregnancy: a systematic review","volume":"81","author":"Sanson","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjmed.2007.08.011_bib38","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1538-7836.2005.01307.x","article-title":"Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis","volume":"3","author":"Pabinger","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.amjmed.2007.08.011_bib39","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2006.06317.x","article-title":"The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis","volume":"135","author":"De Stefano","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib40","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2002-01-0149","article-title":"Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism","volume":"100","author":"Pabinger","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2007.08.011_bib41","doi-asserted-by":"crossref","first-page":"627S","DOI":"10.1378\/chest.126.3_suppl.627S","article-title":"Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Bates","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2007.08.011_bib42","first-page":"187","article-title":"Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy","volume":"3","author":"James","year":"2005","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib43","first-page":"1333","article-title":"Antiphospholipid syndrome: obstetric diagnosis, management, and controversies","volume":"101","author":"Branch","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib44","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2003-12-4250","article-title":"Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder","volume":"103","author":"Gris","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2007.08.011_bib45","series-title":"Thromboembolism in pregnancy","year":"2000"},{"key":"10.1016\/j.amjmed.2007.08.011_bib46","first-page":"333","article-title":"Inherited thrombophilias in pregnant patients: detection and treatment paradigm","volume":"99","author":"Lockwood","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib47","series-title":"The Developing Human: Clinically Oriented Embryology","first-page":"83","article-title":"Organogenetic period: The fourth to eighth weeks","author":"Moore","year":"1998"},{"key":"10.1016\/j.amjmed.2007.08.011_bib48","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1542\/peds.111.S1.1136","article-title":"Binge drinking in the preconception period and the risk of unintended pregnancy: implications for women and their children","volume":"111","author":"Naimi","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.amjmed.2007.08.011_bib49","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJM198611273152205","article-title":"Risks of anticoagulant therapy in pregnant women with artificial heart valves","volume":"315","author":"Iturbe-Alessio","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2007.08.011_bib50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1471-0528.2000.tb11696.x","article-title":"Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves","volume":"107","author":"Sadler","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.amjmed.2007.08.011_bib51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archinte.160.2.191","article-title":"Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature","volume":"160","author":"Chan","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2007.08.011_bib52","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.ajog.2004.05.064","article-title":"Pregnancy outcome in women with prosthetic heart valves","volume":"191","author":"Nassar","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0020-7292(02)00186-8","article-title":"The risk of fetal loss associated with warfarin anticoagulation","volume":"78","author":"Blickstein","year":"2002","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.amjmed.2007.08.011_bib54","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/021849230201000405","article-title":"Effect of oral anticoagulant during pregnancy with prosthetic heart valve","volume":"10","author":"Srivastava","year":"2002","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1016\/j.amjmed.2007.08.011_bib55","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/hrt.82.1.23","article-title":"Anticoagulation in pregnant women with mechanical heart valve prostheses","volume":"82","author":"Meschengieser","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.amjmed.2007.08.011_bib56","first-page":"358","article-title":"Pregnancy in patients with prosthetic heart valves: an experience with 45 pregnancies","volume":"51","author":"Chen","year":"1982","journal-title":"Q J Med"},{"key":"10.1016\/j.amjmed.2007.08.011_bib57","first-page":"35","article-title":"Risk of warfarin during pregnancy with mechanical valve prostheses","volume":"99","author":"Cotrufo","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib58","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1055\/s-0037-1615641","article-title":"Coumarins during pregnancy: long-term effects on growth and development of school-age children","volume":"85","author":"Wesseling","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjmed.2007.08.011_bib59","first-page":"314","article-title":"Lack of anti-factor Xa activity in umbilical cord vein samples after subcutaneous administration of heparin or low molecular mass heparin in pregnant women","volume":"23","author":"Harenberg","year":"1993","journal-title":"Haemostasis"},{"key":"10.1016\/j.amjmed.2007.08.011_bib60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-2007-1022782","article-title":"Placental transfer of low-molecular weight heparin","volume":"55","author":"Schneider","year":"1995","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.amjmed.2007.08.011_bib61","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0002-9378(13)90457-9","article-title":"Bone mineral density during long-term prophylaxis with heparin in pregnancy","volume":"170","author":"Dahlman","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib62","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0002-9378(94)70299-3","article-title":"A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry","volume":"170","author":"Barbour","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib63","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ajog.2006.06.080","article-title":"Bone density changes in women who receive thromboprophylaxis in pregnancy","volume":"195","author":"Casele","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib64","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/0002-9378(93)90378-V","article-title":"Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin","volume":"168","author":"Dahlman","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib65","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1067\/mob.2001.114690","article-title":"Heparin-induced thrombocytopenia is rare in pregnancy","volume":"185","author":"Fausett","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib66","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/humrep\/deh115","article-title":"Prospective observational study of bone mineral density during pregnancy: low molecular weight heparin versus control","volume":"19","author":"Carlin","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.amjmed.2007.08.011_bib67","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.ajog.2005.10.552","article-title":"Bruising in women undergoing thromboprophylaxis in pregnancy","volume":"193","author":"Casele","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib68","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00223-002-2091-5","article-title":"Effects of fondaparinux compared with dalteparin, enoxaparin and unfractionated heparin on human osteoblasts","volume":"73","author":"Matziolis","year":"2003","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.amjmed.2007.08.011_bib69","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00003088-200241002-00007","article-title":"Fondaparinux sodium does not cross the placental barrier: study using the in-vitro human dually perfused cotyledon model","volume":"41","author":"Lagrange","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.amjmed.2007.08.011_bib70","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1056\/NEJM200404293501825","article-title":"Minor transplacental passage of fondaparinux in vivo","volume":"350","author":"Dempfle","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2007.08.011_bib71","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation","volume":"10","author":"Girardi","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.amjmed.2007.08.011_bib72","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1182\/blood-2006-03-009548","article-title":"Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy","volume":"108","author":"Mazzolai","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2007.08.011_bib73","doi-asserted-by":"crossref","first-page":"204S","DOI":"10.1378\/chest.126.3_suppl.204S","article-title":"The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Ansell","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2007.08.011_bib74","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1093\/humrep\/12.10.2167","article-title":"Thromboembolic disease associated with ovarian stimulation and assisted conception techniques","volume":"12","author":"Stewart","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.amjmed.2007.08.011_bib75","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2007.08.011_bib76","first-page":"305","article-title":"Platelets: an update on diagnosis and management of thrombocytopenic disorders","volume":"282","author":"McCrae","year":"2001","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.1016\/j.amjmed.2007.08.011_bib77","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/107602960000600401","article-title":"Thromboembolic prophylaxis with danaparoid (Orgaran) in a high-thrombosis-risk pregnant woman with a history of heparin-induced thrombocytopenia (HIT) and Widal\u2019s disease","volume":"6","author":"Macchi","year":"2000","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.amjmed.2007.08.011_bib78","first-page":"466","article-title":"Danaparoid thromboprophylaxis in pregnant women with heparin-induced thrombocytopenia","volume":"109","author":"Woo","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.amjmed.2007.08.011_bib79","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1055\/s-2002-35284","article-title":"Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactation","volume":"28","author":"Lindhoff-Last","year":"2002","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.amjmed.2007.08.011_bib80","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0029-7844(97)00365-7","article-title":"Successful use of danaparoid in treatment of heparin-induced thrombocytopenia during twin pregnancy","volume":"90","author":"Gill","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib81","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000010216","article-title":"Management of heparin-associated thrombocytopenia in pregnancy with subcutaneous r-hirudin","volume":"49","author":"Huhle","year":"2000","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.amjmed.2007.08.011_bib82","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/ajh.1129","article-title":"Management of heparin allergy in pregnancy","volume":"67","author":"Aijaz","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib83","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.mbc.0000214710.19116.40","article-title":"Fondaparinux as anticoagulant in a pregnant woman with heparin allergy","volume":"17","author":"Wijesiriwardana","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.amjmed.2007.08.011_bib84","first-page":"370","article-title":"Pregnancy after mechanical mitral valve replacement","volume":"12","author":"Vural","year":"2003","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.amjmed.2007.08.011_bib85","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1136\/bmj.1.6076.1564","article-title":"May mothers given warfarin breast-feed their infants?","volume":"1","author":"Orme","year":"1977","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2007.08.011_bib86","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1542\/peds.108.3.776","article-title":"Transfer of drugs and other chemicals into human milk","volume":"108","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.amjmed.2007.08.011_bib87","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0002-9378(65)90518-1","article-title":"Placental transport of heparin","volume":"93","author":"Flessa","year":"1965","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib88","first-page":"243","article-title":"Absence of transplacental passage of the low molecular weight heparin enoxaparin","volume":"30","author":"Dimitrakakis","year":"2000","journal-title":"Haemostasis"},{"key":"10.1016\/j.amjmed.2007.08.011_bib89","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1055\/s-0038-1646338","article-title":"Use of low molecular weight heparin in pregnancy","volume":"68","author":"Melissari","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjmed.2007.08.011_bib90","first-page":"1011","article-title":"Successful use of heparinoids in a pregnancy complicated by allergy to heparin","volume":"108","author":"Taylor","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/j.amjmed.2007.08.011_bib91","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0750-7658(00)00309-9","article-title":"Treatment with danaparoid during pregnancy for a woman with a cutenous allergy to low-molecular-weight heparin","volume":"19","author":"de Saint-Blanquat","year":"2000","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.amjmed.2007.08.011_bib92","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00001721-200307000-00009","article-title":"Prophylactic use of danaparoid in high-risk pregnancy with heparin-induced thrombocytopaenia-positive skin reaction","volume":"14","author":"Myers","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.amjmed.2007.08.011_bib93","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1345\/aph.1A204","article-title":"Treatment of heparin-induced thrombocytopenia","volume":"36","author":"Dager","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjmed.2007.08.011_bib94","first-page":"202","article-title":"Pharmacological survey of recombinant hirudin","volume":"43","author":"Markwardt","year":"1988","journal-title":"Pharmazie"},{"key":"10.1016\/j.amjmed.2007.08.011_bib95","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(00)82018-8","article-title":"Hirudin treatment in a breastfeeding woman","volume":"355","author":"Lindhoff-Last","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2007.08.011_bib96","first-page":"147","article-title":"Fondaparinux (ARIXTRA) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins","volume":"88","author":"Parody","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.amjmed.2007.08.011_bib97","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1055\/s-0037-1613092","article-title":"Absence of placental transfer of pentasaccharide (Fondaparinux, Arixtra) in the dually perfused human cotyledon in vitro","volume":"87","author":"Lagrange","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjmed.2007.08.011_bib98","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1067\/mob.2001.117657","article-title":"Enoxaparin treatment in women with mechanical heart valves during pregnancy","volume":"185","author":"Rowan","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib99","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/bmj.322.7282.329","article-title":"Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review","volume":"322","author":"Duley","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2007.08.011_bib100","first-page":"1319","article-title":"Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review","volume":"101","author":"Coomarasamy","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib101","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/jat\/6.2.64","article-title":"A study of salicylate and caffeine excretion in the breast milk of two nursing mothers","volume":"6","author":"Bailey","year":"1982","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib102","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/clpt.1981.87","article-title":"Analgesic drugs in breast milk and plasma","volume":"29","author":"Findlay","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2007.08.011_bib103","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/00016348509155155","article-title":"Side and site of deep vein thrombosis in women using oral contraceptives","volume":"64","author":"Kierkegaard","year":"1985","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.amjmed.2007.08.011_bib104","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0010-7824(85)90072-1","article-title":"Deep vein thrombosis and the oestrogen content in oral contraceptives: an epidemiological analysis","volume":"31","author":"Kierkegaard","year":"1985","journal-title":"Contraception"},{"key":"10.1016\/j.amjmed.2007.08.011_bib105","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/bjs.1800521028","article-title":"The iliac compression syndrome","volume":"52","author":"Cockett","year":"1965","journal-title":"Br J Surg"},{"key":"10.1016\/j.amjmed.2007.08.011_bib106","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1055\/s-0038-1648485","article-title":"Venous thrombosis during pregnancy: leg and trimester of presentation","volume":"67","author":"Ginsberg","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjmed.2007.08.011_bib107","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.amjcard.2003.09.057","article-title":"A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis","volume":"93","author":"Goldhaber","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib108","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1182\/blood-2002-03-0965","article-title":"How we manage venous thromboembolism during pregnancy","volume":"100","author":"Bates","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2007.08.011_bib109","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1182\/asheducation-2003.1.520","article-title":"Thrombotic disorders: diagnosis and treatment","volume":"X","author":"Schafer","year":"2003","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.1016\/j.amjmed.2007.08.011_bib110","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ajog.2004.05.050","article-title":"A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation","volume":"191","author":"Barbour","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib111","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0002-9378(99)70091-8","article-title":"Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy","volume":"181","author":"Casele","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib112","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00001721-199806000-00006","article-title":"A pharmacokinetic study of dalteparin (Fragmin) during late pregnancy","volume":"9","author":"Blomback","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.amjmed.2007.08.011_bib113","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/0002-9378(95)91362-9","article-title":"Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy","volume":"173","author":"Brancazio","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib114","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1471-0528.2003.02182.x","article-title":"Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy","volume":"110","author":"Jacobsen","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.amjmed.2007.08.011_bib115","first-page":"1307","article-title":"A longitudinal study of maternal dose response to low molecular weight heparin in pregnancy","volume":"101","author":"Sephton","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib116","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0002-9378(03)00953-0","article-title":"Tinzaparin sodium for thrombosis treatment and prevention during pregnancy","volume":"190","author":"Smith","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2007.08.011_bib117","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/00006254-199507000-00020","article-title":"Use of thrombolytics for the treatment of thromboembolic disease during pregnancy","volume":"50","author":"Turrentine","year":"1995","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.amjmed.2007.08.011_bib118","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0049-3848(00)00386-8","article-title":"Low molecular weight heparin and neuraxial anesthesia","volume":"101","author":"Horlocker","year":"2001","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjmed.2007.08.011_bib119","first-page":"371","article-title":"Pneumatic compression devices for prophylaxis of deep venous thrombosis (DVT)","volume":"52","author":"Baker","year":"1986","journal-title":"Am Surg"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934307007413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934307007413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:46:21Z","timestamp":1757580381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934307007413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":119,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0002934307007413"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2007.08.011","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention and Management of Venous Thromboembolism in Pregnancy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2007.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}